All Blogs

Aug 01, 2023

FDA Expands GSK’s Jemperli Approval for Endometrial Cancer GSK plc announced that the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab) in combination with carboplatin and paclitaxel, followed by Jemperli as a single agent for the treatment of adult patients with mismatch repair deficient...

Jul 31, 2023

Cocaine use disorder also known as cocaine dependence is a chronic condition that affects millions of people worldwide. Cocaine is a highly addictive central nervous system stimulant derived from the leaves of the coca plant and produces a range of effects on the mind and body, including short-lived euphoria, incre...

Jul 28, 2023

“Sleep is a fundamental pillar of our overall health and well-being, and a continued lack of sleep can significantly impact many aspects of daily life”. Insomnia and its symptoms Insomnia is a common sleep-wake disorder where one has difficulty initiating or maintaining sleep or dissatisfaction with sleep q...

Jul 27, 2023

VARON Launched the Game-changer in the Field--New VP Series Portable Oxygen Concentrator On July 19, 2023, VARON, a leading oxygen concentrator manufacturer, announced the launch of a game-changer portable oxygen concentrator VP-2.  A new member of the VP series, VP-2 is incorporated with innovative tech...

Jul 26, 2023

Over the past few years, there has been a remarkable advancement in the artificial organs market. Cutting-edge research, technological innovations, and breakthroughs in the artificial organ segment have revolutionized healthcare and extended the lives of countless individuals facing organ failure or similar impairm...

Jul 25, 2023

Gilead To Discontinue Phase III ENHANCE Study of Magrolimab Plus Azacitidine in Higher-Risk MDS Gilead Sciences, Inc. reported that the Phase III ENHANCE study in higher-risk myelodysplastic syndromes (MDS) has been halted due to futility based on a planned analysis. The safety data in this trial are consistent ...

Jul 24, 2023

Multiple sclerosis is an unpredictable, autoimmune disease that affects the central nervous system. Multiple sclerosis is believed to impact almost 1 million Americans, and the disease manifests itself in a variety of ways. Because nerves are affected in different ways and exhibit a variety of symptoms, no two case...

Jul 21, 2023

Sanofi’s immunization strategy is taking shape, owing to an authorization that could drive the company and its partner AstraZeneca to the forefront of the respiratory syncytial virus (RSV) treatment battle. The FDA approved Sanofi and AstraZeneca’s monoclonal antibody Beyfortus, also known as nirsevimab, as a preve...

Jul 20, 2023

Relievant Medsystems Launched New Tools for its Ablation System On June 14, 2023, Relievant Medsystems announced that it launched its next-generation access instruments for the Intracept procedure. Chronic vertebrogenic low back pain is treated with Intracept, a minimally invasive, same-day, outpatient proced...

Aug 09, 2025

FemTech, short for “Female Technology,” is a rapidly growing sector in healthcare that focuses on leveraging digital tools like mobile apps, wearables, diagnostics, and telehealth to address women’s health needs. Coined by entrepreneur Ida Tin in 2016, the term captures a movement that began with menstrual tracking...